| Current IVIG coreSPC indication and dosing: |
| Hypogammaglobulinaemia and recurrent bacterial infections in patients with CLL, in whom prophylactic antibiotics have failed. |
| The recommended dose is 0.2–0.4 g/kg every 3–4 weeks. |
| Current draft SCIG coreSPC indication and dosing: |
| Hypogammaglobulinaemia and recurrent bacterial infections in patients with CLL, in whom prophylactic antibiotics have failed or are contra-indicated. |
| For dosing see PID/SCIG above. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.